Walmart Inc. (0R1W)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 120.44 |
|---|---|
| 52-week range | 97.87 – 135.16 |
| Return, 1 month / 3 months | +9.9% / +10.6% |
| Return, 1 year / 3 years | +13.2% / +179.9% |
| Trend | Uptrend |
| RSI (14) | 74 |
| Volatility (1 year) | 27.3% |
| Worst drawdown (1 year) | -23.1% |
| Average daily value traded | 4.87M USD |
| Dividend yield | 0.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Walmart Inc. is a retail company based in Bentonville, Arkansas. It runs discount department stores, warehouse clubs and grocery outlets, offering food, household goods, clothing, electronics and health and beauty products. Its customers are everyday shoppers, and it also serves businesses through its membership warehouse business. The company operates stores and online shopping services in the United States and in several other countries, and it provides related services such as pharmacy and financial offerings to retail customers.
On this site Walmart Inc. appears as a stock on the London Exchange (UK), code 0R1W, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Walmart Inc. (0R1W) trades on the London Exchange in UK. It last closed at USD 120.44 on 22 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,531 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 13.2% and over the last three months it rose 10.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 50 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | 2.1% | ||
| From 52-week high | -10.5% | ||
| Momentum | 55 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 10.6% | ||
| 6-month return | -6.8% | ||
| 12-month return, skipping the last month | 3.0% | ||
| Stability (higher is calmer) | 67 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 27.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -23.1% | ||
| Liquidity | 68 · Fair | Moderate trading activity. | |
| Average daily value traded | 4.87M USD | ||
| Zero-volume days | 0.0% | ||
| Income | 48 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.8% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Income: Dividend is small or irregular.
Returns
| 1 week | +1.6% |
|---|---|
| 1 month | +9.9% |
| 3 months | +10.6% |
| 6 months | −6.8% |
| 1 year | +13.2% |
| 3 years | +179.9% |
| 5 years | +160.8% |
Signals
| 50-day / 200-day average | 109.43 / 117.94 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.68 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 21 Aug 2026 | USD 0.2475 |
| 8 May 2026 | USD 0.2475 |
| 20 Mar 2026 | USD 0.2475 |
| 12 Dec 2025 | USD 0.2350 |
| 14 Aug 2025 | USD 0.2350 |
| 8 May 2025 | USD 0.2350 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.